pEGFP-C2-NLRP3 Citations (9)
Originally described in: An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages.Khare S, Dorfleutner A, Bryan NB, Yun C, Radian AD, de Almeida L, Rojanasakul Y, Stehlik C Immunity. 2012 Mar 23;36(3):464-76. doi: 10.1016/j.immuni.2012.02.001. Epub 2012 Feb 21. PubMed Journal
Articles Citing pEGFP-C2-NLRP3
| Articles |
|---|
| The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by Impeding Its Assembly and by Mediating Its Selective Autophagy. Mehto S, Jena KK, Nath P, Chauhan S, Kolapalli SP, Das SK, Sahoo PK, Jain A, Taylor GA, Chauhan S. Mol Cell. 2019 Feb 7;73(3):429-445.e7. doi: 10.1016/j.molcel.2018.11.018. Epub 2019 Jan 3. PubMed |
| Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation. Darweesh M, Kamel W, Gavrilin MA, Akusjarvi G, Svensson C. Front Immunol. 2019 Nov 28;10:2791. doi: 10.3389/fimmu.2019.02791. eCollection 2019. PubMed |
| Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis. Graustein AD, Berrington WR, Buckingham KJ, Nguyen FK, Joudeh LL, Rosenfeld M, Bamshad MJ, Gibson RL, Hawn TR, Emond MJ. Am J Respir Cell Mol Biol. 2021 Aug;65(2):157-166. doi: 10.1165/rcmb.2020-0257OC. PubMed |
Cellular stress promotes NOD1/2-dependent inflammation via the endogenous metabolite sphingosine-1-phosphate.
Pei G, Zyla J, He L, Moura-Alves P, Steinle H, Saikali P, Lozza L, Nieuwenhuizen N, Weiner J, Mollenkopf HJ, Ellwanger K, Arnold C, Duan M, Dagil Y, Pashenkov M, Boneca IG, Kufer TA, Dorhoi A, Kaufmann SH.
EMBO J. 2021 Jul 1;40(13):e106272. doi: 10.15252/embj.2020106272. Epub 2021 May 4.
PubMed
Associated Plasmids |
| Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis. Yuan R, Zhao W, Wang QQ, He J, Han S, Gao H, Feng Y, Yang S. Pharmacol Res. 2021 Aug;170:105748. doi: 10.1016/j.phrs.2021.105748. Epub 2021 Jul 1. PubMed |
| Split-luciferase complementary assay of NLRP3 PYD-PYD interaction indicates inflammasome formation during inflammation. Isazadeh M, Amandadi M, Haghdoust F, Lotfollazadeh S, Orzaez M, Hosseinkhani S. Anal Biochem. 2022 Feb 1;638:114510. doi: 10.1016/j.ab.2021.114510. Epub 2021 Dec 1. PubMed |
| GSK3beta mediates the spatiotemporal dynamics of NLRP3 inflammasome activation. Arumugam S, Qin Y, Liang Z, Han SN, Boodapati SLT, Li J, Lu Q, Flavell RA, Mehal WZ, Ouyang X. Cell Death Differ. 2022 Oct;29(10):2060-2069. doi: 10.1038/s41418-022-00997-y. Epub 2022 Apr 27. PubMed |
| NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation. Yu T, Hou D, Zhao J, Lu X, Greentree WK, Zhao Q, Yang M, Conde DG, Linder ME, Lin H. Cell Rep. 2024 Apr 23;43(4):114070. doi: 10.1016/j.celrep.2024.114070. Epub 2024 Apr 6. PubMed |
| Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1beta production in human macrophages and microglia. Liang Z, Damianou A, Vendrell I, Jenkins E, Lassen FH, Washer SJ, Grigoriou A, Liu G, Yi G, Lou H, Cao F, Zheng X, Fernandes RA, Dong T, Tate EW, Di Daniel E, Kessler BM. Cell Rep. 2024 May 28;43(5):114152. doi: 10.1016/j.celrep.2024.114152. Epub 2024 Apr 25. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.